Release Date: 31/01/18 09:54 Summary: Quarterly Activities & Cashflow Report December 2017 Price Sensitive: Yes Download Document 1.52MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%